SCHEMBL7888945

SCHEMBL7888945

CCn1cc(C(=O)C(=O)c2cccc(Br)c2)cn1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 2/20 0.46
TSHR P16473 1/20 0.46
LMNA P02545 3/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 4/20 0.43
CYP2C19 P33261 1/20 0.43
GFER P55789 1/20 0.43
PARP1 P09874 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 5/20 0.42
TP53 P04637 1/20 0.42
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
KDM1A O60341 1/20 0.41
ELANE P08246 1/20 0.41
PLAU P00749 1/20 0.41
ALPL P05186 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3583124 0.84 ROCK1 (0.41) KMT2ANPSR1TSHRHPGDMAPT
SCHEMBL7884497 0.82 ALPL (0.48) NPSR1TSHRHPGDMAPTPARP1
SCHEMBL7878068 0.81 TSHR (0.38) KMT2ANPSR1TSHRLMNAHPGD
SCHEMBL6670439 0.76 PARP1 (0.68) KMT2ANPSR1TSHRHPGDPARP1
SCHEMBL3016241 0.75 L3MBTL1 (0.54) KMT2ANPSR1TSHRLMNAHPGD
SCHEMBL3581022 0.74 PARP1 (0.45) KMT2ANPSR1TSHRHPGDMAPT
SCHEMBL8379718 0.73 KCNH2 (0.61) KMT2ALMNAMAPTL3MBTL1ALDH1A1
SCHEMBL12159798 0.71 L3MBTL1 (0.53) KMT2ANPSR1TSHRLMNAHPGD
SCHEMBL553834 0.71 L3MBTL1 (0.73) KMT2ANPSR1TSHRLMNAHPGD
SCHEMBL4229652 0.70 CES2 (0.61) KMT2AHPGDMAPTPARP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168106-A1 Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation WYETH LLC (US) 2010-07-01 US disclosed
US-7705030-B2 Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation WYETH LLC (US) 2010-04-27 US disclosed
US-20080306091-A1 AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION WYETH (US) 2008-12-11 US disclosed
US-7417047-B2 Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation WYETH (US) 2008-08-26 US disclosed
US-20070004786-A1 Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation WYETH (US) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004786-A1 Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation BACE1, BACE2, APP KMT2A 3216/4885NPSR1 1670/4885TSHR 4731/4885
US-20080306091-A1 AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION BACE1, BACE2, APP KMT2A 3216/4885NPSR1 1670/4885TSHR 4731/4885
US-20100168106-A1 Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation BACE1, BACE2, APP KMT2A 2986/4885NPSR1 1791/4885TSHR 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.